A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
临床有效 AKT 抑制的假定生物标志物特征：体外、体内和临床数据的相关性表明 mTORC1 通路调节的重要性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.6153
Cheraghchi-Bashi Azadeh, Parker Christine A, Curry Ed, Salazar Jean-Frederic, Gungor Hatice, Saleem Azeem, Cunnea Paula, Rama Nona, Salinas Cristian, Mills Gordon B, Morris Shannon R, Kumar Rakesh, Gabra Hani, Stronach Euan A
